Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

September 2, 2021 0

Can-Fite Biopharma Good News We learned, from Petach Tikva, Israel, that Can-Fite Biopharma (CANF) – a …

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

September 2, 2021 0

TCR2 Therapeutics TCR2 Therapeutics (TCRR) is a clinical-stage cell therapy company developing a pipeline of novel T …

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

August 31, 2021 0

The most important news in biological sciences is the high degree of success the biological revolution …

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed Phase 2b Study in Alzheimer’s Patients

August 27, 2021 0

Cassava Sciences Released a Statement Cassava Sciences, Inc. (SAVA) – a biotechnology company focused on Alzheimer’s …

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

August 27, 2021 0

Agenus Good News for Balstilimab Monotherapy Agenus (AGEN) announced that results from a global Phase 2 …

Cassava Sciences Issued a Response to Claims Posted After Market Yesterday. See Also: Cassava Sciences Good News

August 25, 2021 0

Cassava Sciences Responds to Misleading Posts Cassava Sciences (SAVA) today issued a response to claims that …

Cara Therapeutics and Vifor Pharma Announced the U.S. FDA Approval of KORSUVA™

August 24, 2021 0

Cara Therapeutics and Vifor Pharma Granted US FDA Approval of KORSUVA™ Indeed, the U.S. Food and …

Axsome Therapeutics: Treating Major Depressive Disorder. Vivos Therapeutics: Improving the Treatment of Obstructive Sleep Apnea

August 23, 2021 0

Axsome Therapeutics Inc and Major Depressive Disorder In a teleconference on August 20, 2021, the U.S. …

The US FDA Granted Fast Track Designation for Sutro Biopharma Product STRO-002

August 18, 2021 0

Sutro Biopharma Inc Granted Fast Track Designation for STRO-002 by the US FDA Sutro Biopharma Inc …

Why Virpax Pharmaceuticals Stock Soared on Two Consecutive Days

August 18, 2021 0

Virpax Pharmaceuticals Virpax Pharmaceuticals (VRPX) - a company specializing in developing product candidates for pain management, CNS …

BeiGene Ltd and EUSA Pharma Product QARZIBA® Approval from China NMPA. See Also: Sagimet Sciences and NASH

August 17, 2021 0

BeiGene Ltd and EUSA Pharma Receive Approval from China NMPA for QARZIBA® BeiGene Ltd (BGNE) and EUSA …

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

August 16, 2021 0

Travere Therapeutics Sparsentan for IgAN Positive Results Phase 3 PROTECT Study of Travere Therapeutics (TVTX) product sparsentan …

Akero Therapeutics Inc Q2 Business Updates and Financial Results

August 13, 2021 0

Akero Therapeutics Inc Akero Therapeutics Inc (AKRO) is a clinical-stage cardio-metabolic company developing transformational treatments for …

A Biotechnology Company to Remember and Appreciate

August 12, 2021 0

Vir Biotechnology: What We've Learned from Dr. George Scangos George Scangos, PhD. is the chief executive …

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

August 11, 2021 0

Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

August 9, 2021 0

Agenus Inc News and Q2 Results for 201 Agenus (AGEN) announced results with better than usual …

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0

Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

August 6, 2021 0

Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

August 4, 2021 0

Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

August 3, 2021 0

Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Can-Fite Biopharma Has Encouraging News but Will It Enthuse Investors?

Positive News for TCR2 Therapeutics – The U.S. FDA Granted Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

BioMarin Pharmaceutical Inc Product VOXZOGO® is the First to Prevent Dwarfism in Europe

Cassava Statement Regarding Plasma p-tau Analysis from a Previously Disclosed Phase 2b Study in Alzheimer’s Patients

Agenus Good News: Balstilimab Monotherapy Data Published in Gynecologic Oncology

Cassava Sciences Issued a Response to Claims Posted After Market Yesterday. See Also: Cassava Sciences Good News

Cara Therapeutics and Vifor Pharma Announced the U.S. FDA Approval of KORSUVA™

Axsome Therapeutics: Treating Major Depressive Disorder. Vivos Therapeutics: Improving the Treatment of Obstructive Sleep Apnea

The US FDA Granted Fast Track Designation for Sutro Biopharma Product STRO-002

Why Virpax Pharmaceuticals Stock Soared on Two Consecutive Days

BeiGene Ltd and EUSA Pharma Product QARZIBA® Approval from China NMPA. See Also: Sagimet Sciences and NASH

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

Akero Therapeutics Inc Q2 Business Updates and Financial Results

A Biotechnology Company to Remember and Appreciate

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

A Reevaluation of Prohost Biotech’s Picked Firms

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results